NSE:HCG Statistics
Total Valuation
NSE:HCG has a market cap or net worth of INR 76.50 billion. The enterprise value is 92.07 billion.
Market Cap | 76.50B |
Enterprise Value | 92.07B |
Important Dates
The last earnings date was Friday, May 23, 2025.
Earnings Date | May 23, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
NSE:HCG has 139.35 million shares outstanding. The number of shares has increased by 0.73% in one year.
Current Share Class | 139.35M |
Shares Outstanding | 139.35M |
Shares Change (YoY) | +0.73% |
Shares Change (QoQ) | -0.64% |
Owned by Insiders (%) | 13.75% |
Owned by Institutions (%) | 15.99% |
Float | 36.05M |
Valuation Ratios
The trailing PE ratio is 174.84 and the forward PE ratio is 95.76. NSE:HCG's PEG ratio is 1.92.
PE Ratio | 174.84 |
Forward PE | 95.76 |
PS Ratio | 3.44 |
PB Ratio | 7.73 |
P/TBV Ratio | 17.25 |
P/FCF Ratio | 70.68 |
P/OCF Ratio | 24.12 |
PEG Ratio | 1.92 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 23.73, with an EV/FCF ratio of 85.06.
EV / Earnings | 207.32 |
EV / Sales | 4.14 |
EV / EBITDA | 23.73 |
EV / EBIT | 52.10 |
EV / FCF | 85.06 |
Financial Position
The company has a current ratio of 0.81, with a Debt / Equity ratio of 1.86.
Current Ratio | 0.81 |
Quick Ratio | 0.72 |
Debt / Equity | 1.86 |
Debt / EBITDA | 4.74 |
Debt / FCF | 16.97 |
Interest Coverage | 1.14 |
Financial Efficiency
Return on equity (ROE) is 5.26% and return on invested capital (ROIC) is 4.43%.
Return on Equity (ROE) | 5.26% |
Return on Assets (ROA) | 3.52% |
Return on Invested Capital (ROIC) | 4.43% |
Return on Capital Employed (ROCE) | 7.05% |
Revenue Per Employee | 3.61M |
Profits Per Employee | 72,211 |
Employee Count | 6,150 |
Asset Turnover | 0.71 |
Inventory Turnover | 29.59 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +50.66% in the last 52 weeks. The beta is -0.12, so NSE:HCG's price volatility has been lower than the market average.
Beta (5Y) | -0.12 |
52-Week Price Change | +50.66% |
50-Day Moving Average | 558.40 |
200-Day Moving Average | 488.35 |
Relative Strength Index (RSI) | 43.83 |
Average Volume (20 Days) | 292,660 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:HCG had revenue of INR 22.23 billion and earned 444.10 million in profits. Earnings per share was 3.14.
Revenue | 22.23B |
Gross Profit | 8.07B |
Operating Income | 1.76B |
Pretax Income | 569.60M |
Net Income | 444.10M |
EBITDA | 3.87B |
EBIT | 1.76B |
Earnings Per Share (EPS) | 3.14 |
Balance Sheet
The company has 3.48 billion in cash and 18.37 billion in debt, giving a net cash position of -14.90 billion or -106.89 per share.
Cash & Cash Equivalents | 3.48B |
Total Debt | 18.37B |
Net Cash | -14.90B |
Net Cash Per Share | -106.89 |
Equity (Book Value) | 9.90B |
Book Value Per Share | 66.43 |
Working Capital | -2.03B |
Cash Flow
In the last 12 months, operating cash flow was 3.17 billion and capital expenditures -2.09 billion, giving a free cash flow of 1.08 billion.
Operating Cash Flow | 3.17B |
Capital Expenditures | -2.09B |
Free Cash Flow | 1.08B |
FCF Per Share | 7.77 |
Margins
Gross margin is 36.31%, with operating and profit margins of 7.92% and 2.00%.
Gross Margin | 36.31% |
Operating Margin | 7.92% |
Pretax Margin | 2.56% |
Profit Margin | 2.00% |
EBITDA Margin | 17.42% |
EBIT Margin | 7.92% |
FCF Margin | 4.87% |
Dividends & Yields
NSE:HCG does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.73% |
Shareholder Yield | n/a |
Earnings Yield | 0.58% |
FCF Yield | 1.41% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |